Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
APVO
#4972
Aptevo Therapeutics Inc
5.390
0
USD
+7.16%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+7.16%
Monthly Change
+16.04%
6 month change
-20.15%
Year Change
-20.15%
Previous Close
5.030
0
Open
5.390
0
Bid
Ask
Low
5.390
0
High
5.390
0
Volume
2
Markets
US Stock Market
Healthcare
APVO
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Cash from operating activities
-5.76 M
-6.58 M
-7.09 M
-6.69 M
-5.24 M
-25.59 M
Cash from investing activities
—
—
—
—
—
—
Cash from financing activities
6.72 M
0
14.36 M
18.34 M
5.79 M
38.5 M
Free cash flow
-5.76 M
-6.58 M
-7.09 M
-6.69 M
-5.24 M
-25.59 M
News
Aptevo Therapeutics (APVO) Upgraded to Buy: Here's Why
Aptevo Therapeutics stock tumbles despite positive trial data
Aptevo Therapeutics announces leadership changes as CEO retires
Aptevo Therapeutics stock jumps after securing $60 million equity line
Aptevo secures $60 million equity line of credit to fund operations
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested - TipRanks.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.04%
Aptevo Therapeutics stock tumbles after announcing 1-for-18 reverse split
Aptevo Therapeutics to implement 1-for-18 reverse stock split
What's Going On With Aptevo Therapeutics Stock Today? - Aptevo Therapeutics (NASDAQ:APVO)
Aptevo’s AML therapy shows strong safety profile in phase 1b/2 trial